SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-023984
Filing Date
2022-04-11
Accepted
2022-04-11 16:49:14
Documents
2
Period of Report
2022-04-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2199
2 POA DOCUMENT poa.txt EX-24 3101
  Complete submission text file 0001209191-22-023984.txt   6769
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Issuer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O VAXCYTE, INC. 825 INDUSTRIAL ROAD, SUITE 300 SAN CARLOS CA 94070
Business Address
Eydelman Mikhail (Reporting) CIK: 0001918033 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39323 | Film No.: 22820152